We analyzed the T cell receptor (TCR) repertoire of bronchoalveolar lavage fluid (BALF) lymphocytes from polymyositis (PM) and dermatomyositis (DM) patients with interstitial pneumonitis (IP) to elucidate the pathogenic mechanisms of IP in these disorders. Samples from 2 PM patients, 1 DM patient and 3 healthy controls were used. RNA was isolated from BALF, cDNAs were synthesized, and family PCR and Southern blot analysis were performed by primers specific for TCR BV1-25 and TCR BC to determine TCR repertoire. We examined single-strand conformation polymorphism (SSCP) to evaluate T cell clonality. The CDR3 region of TCR BV genes in BALF T cells were determined by DNA sequencer. Our examination showed that TCR repertoire of T cells in BALF was heterogeneous both in patients with PM/DM and control subjects. SSCP analysis demonstrated an increased number of accumulated T cell clones in BALF of three PM/DM patients, but not in the healthy subjects and the junctional sequence analysis showed the presence of conserved amino acid motifs (RGS, GLA, LQG, SGG, DRG, GTS, TSGR, GGS, GQA, GAG, GTG) in the TCR-CDR3 region of BALF lymphocytes from PM/DM patients, which were not detected in the control. Our findings suggest that T cells in BALF may recognize the restricted antigen and accumulate via antigen-driven stimulation, suggesting that T cells may play a crucial role in the development of IP in patients with PM/DM.
Introduction
Polymyositis (PM) and dermatomyositis (DM) are systemic inflammatory disorders that affect skeletal muscles and various other organ systems including the lungs. Pulmonary interstitial lung disease (ILD) is the most frequent pulmonary pathological finding recognized to be associated with PM/DM. Recent advances in biotechnology in the field of bronchoalveolar lavage (BAL) have provided considerable information on the alveolar cellular components in PM/DM with IP (1) . Pulmonary damage and fibrosis represent the consequences of immune response and inflammatory process. Previous studies showed that lymphocytes, especially T cells, and alveolar macrophages play a central role in the pathogenesis of PM/ DM with IP, although the mechanism that triggers these cells has not been elucidated (2) .
T cells recognize antigens in the context of major histocompatibility complex (MHC) on antigen-presenting cells (APC) through an antigen receptor, the T cell receptor (TCR). Several groups investigating TCR genes in autoimmune diseases such as rheumatoid arthritis (3), Sjögren's syndrome (4, 5) , and multiple sclerosis (6, 7) among other diseases, have demonstrated that T cells accumulate oligoclonally in the inflammatory lesions. Furthermore, conserved amino acid motifs have been observed in the CDR3 region of TCR gene, but no skewed usage of TCR genes (6, 7) .
Several studies have examined TCR genes of BAL fluid (BALF) T cells in patients with various lung diseases such as sarcoidosis, bronchial asthma, and idiopathic pulmonary fibrosis (IPF). Moller and colleagues (8) demonstrated an increased number of TCR BV8 T cells in BALF of patients with sarcoidosis. Zissel et al (9) showed the predominant usage of TCR BV5, BV8, BV12, BV13S3, and BV19 genes in BALF. Bellocq and coworkers (10) found a number of TCR BV19-positive T cells in BALF of patients with sarcoidosis. In asthmatic patients, Hodges et al (11) was no dominant usage of TCR BV genes in BALF T cells in patients with non-atopic asthma (12) . We also reported conserved amino acid motifs in the CDR3 region of the TCR BV genes in clonally expanded BALF T cells of patients with IPF (13) . These findings support the hypothesis that BALF T cells of patients with sarcoidosis, atopic bronchial asthma, and IPF may be induced by antigens on antigenpresenting cells. To our knowledge, there are no reports on the TCR gene of BALF T cells, or possible triggering factors, in patients with IP associated with PM/DM. The present study was conducted to investigate the pathogenesis of IP in PM/DM and analyze the TCR BV repertoire and clonality of T cells infiltrating the lungs. The results showed oligoclonal expansion of T cells in BALF of patients with IP in PM/DM, suggesting antigen-driven stimulation. Furthermore, highly conserved amino acid sequence motifs were identified in the TCR BV CDR3 region of accumulated BALF T cells. The results indicate that BALF T cells in PM/ DM patients with IP recognize a limited epitope on antigens. Based on these findings, we discuss possible pathogenic mechanisms of IP associated with PM/DM.
Materials and methods
Patients and histopathological examination. Two patients with PM and 1 patient with DM were referred to Tsukuba University Hospital. Each patient met the criteria for PM or DM diagnosis, including clinical features, laboratory findings, chest X-ray and chest CT findings, and endoscopic biopsies. We also recruited three healthy subjects who had no respiratoryrelated complaints and negative chest X-ray films. The clinical characteristics of the 3 patients with PM/DM and healthy subjects are summarized in Table I . Written informed consent was obtained from all patients. A transbronchial lung biopsy was performed, and the tissue was stained with hematoxylin and eosin. No open lung biopsy was performed.
Bronchoalveolar lavage and peripheral blood lymphocytes.
BAL was performed on the involved lung segment (right lower lobe and posterior segment) of the 3 patients with IPF and three healthy control subjects. After topical anesthesia, the fiberoptic bronchoscope (Olympus type BF20, Olympus Co., Tokyo, Japan) was advanced into the described segment and wedged, and 50 ml sterile 0.9% saline at 37˚C was injected through the bronchoscope. The latter process was performed three times. The volume of BALF recovered from the involved segment was approximately 100 ml. Cells in BALF were passed through sterile gauze to remove debris. BALF from patients was centrifuged at 20 x g and 4˚C for 10 min, and washed twice with phosphate-buffered saline (PBS). Following cell count, part of the cell mass was subjected to flow cytometric analysis. A number of cells Table I . Characteristics of study population. 
The diagnosis of PM/DM was based on clinical criteria for PM/DM of Bohan and Peter (22) .
a In x10 4 /ml.
-
were stained with monoclonal antibodies (mAbs) against Leu 4 (anti-CD3), Leu 3a (anti-CD4), and Leu 2a (anti-CD8) (Becton Dickinson, Mountain View, CA). After flow cytometry, peripheral blood lymphocytes (PBLs) from patients with IP associated with PM/DM were obtained by Ficoll-Hypaque density gradient centrifugation, and immediately analyzed.
Polymerase chain reaction, Southern blot analysis and singlestrand conformation polymorphism. Total RNA from BALF cells was prepared with Isogen (Nippon Gene Co., Tokyo). PCR and cDNA synthesis were performed as described previously by Sumida et al (4) . Briefly, first-strand cDNA was synthesized from 1 μg total RNA in a 20-μl reaction mixture containing an oligo(dT) primer by avian myeloblastosis virus reverse transcriptase. Amplification was performed with Taq polymerase in 50 μl standard buffer, using 0.2 μl cDNA (corresponding to 10 ng total RNA), with primers specific for 25 different TCR BV genes and BC gene. The sequences of the primers were obtained from previously published data (5) . Denaturing was performed at 95˚C for 1.5 min, annealing at 60˚C for 1.0 min, and extension at 72˚C for 1.0 min, for 30 cycles in a DNA Thermal Cycler (PerkinElmer Corp., Norwork, CT). One-tenth of each amplified PCR product was subjected to 2% agarose gel electrophoresis and transferred to a nylon membrane. Membranes were further hybridized with digoxygenin-labeled TCR BC probe, and visualized using the DIG luminescent detection kit (Boehringer Mannheim, Mannheim, Germany). The digoxygenin-labeled TCR BC probe was synthesized employing the PCR DIG probe synthesis kit (Boehringer Mannheim), with 5'-TCR BC (5'-GAGGATCTGAGAAATGTGACT-3') and 3'-TCR BC (5'-CAAGCACACACGAGGGTAGCCT-3') primers. For individual single-strand conformation polymorphism (SSCP) assays, amplified DNA was diluted (1:20) in a denaturing solution [95% formamide, 10 mM ethylenediaminetetraacetic acid (EDTA), 0.1% bromophenol blue, 0.1% xylene cyanol] at 90˚C for 2 min. Diluted samples (2:1) were subjected to electrophoresis in non-denaturing 5% polyacrylamide gels containing 10% glycerol (14) . Gels were run at 35 W constant power for 2 h. Following electrophoresis, DNA was transferred to Immobilon-S (Millipore Intertech, Bedford, MA), and hybridized with biotinylated TCR BC probe [5'-A (AC) AA (GC) GTGTTCCCACCCGAGGTCGCTGTGTT-3'], streptavidin, biotinylated alkaline phosphatase, and a chemiluminescent substrate system (Plex™ Luminescence kit, Millipore).
Sequencing of cDNA encoding TCR BV genes.
Complementary DNA, encoding TCR BV genes from BALF and PBLs, was purified from polyacrylamide gels for SSCP, and amplified by PCR using the primers described above. PCR products were ligated to plasmids using the TA cloning kit (Invitrogen, San Diego, CA, USA), transformed into competent INV·F' Escherichia coli cells, and grown under appropriate conditions. After selection of TCR BC-positive colonies, plasmid DNA was purified by alkaline lysis for DNA sequencing. Sequencing reactions were performed using an automated DNA sequencer (model 377A, Applied Biosystems, Foster City, CA).
Results

Heterogeneous TCR BV repertoire of BALF T cells in patients with IP associated with PM/DM.
The mean number of lymphocytes was significantly higher in BALF of PM/DM with IP patients (5,300,000/ml) compared with the control (6,200/ml). The majority of expanded lymphocytes were CD8 + T cells, because CD4/CD8 ratio was decreased in PM/DM + IP to 0.43 from 2.5 in the control. To analyze the pathogenesis of IP associated with PM/DM, we examined the TCR repertoire of BALF T cells from the three patients (DM-1, PM-1, and PM-2) using the family PCR method. PBLs from identical patients were used as a control. Table I lists the clinical profiles of PM/DM patients with IP. Chest CT revealed diffuse reticulonodular opacities, honey combing and ground-glass attenuation. Histopathological examination of lung biopsies from these patients showed a large number of mononuclear cells in the inflamed alveolar septa. The pathological changes in the interstitial septa, alveolar spaces, bronchial mucosa, and pleura were similar to those in the lungs of usual interstitial pneumonia (UIP). No infectious agents or parasites were observed, and there was no evidence of vasculitis. TCR analysis showed expression of the majority of TCR BV family genes in both BALF T cells and PBL in all patients (data not shown). These results suggest that the TCR BV repertoire of T cells in the lung is heterogeneous and that there is no restricted predominant usage of TCR BV genes.
Lung-specific T cell clones in patients with IP associated with PM/DM. TCR BV genes in BALF and peripheral T cells were examined by PCR-SSCP in order to investigate the clonality of pulmonary T cells in patients with IP associated with PM/DM. Fig. 1 depicts lung-specific bands that were found in several TCR BV genes of the three IP patients with PM/DM. These bands were detected in TCR BV2, 3, 4, 5, 6, 8, 9, 10, 11, 12, 13, 16, 17, 19, 20, 23, 24 , and 25 genes. The number of bands encoding TCR BV genes in the lung is summarized in Table II . We observed a significant increase in the number of expanded clones in BALF of three IP patients (27, 23 and 21 clones), compared with three healthy subjects (6, 9 and 8 clones) (p<0.05). These results indicate accumulation of some T cells in the lungs of PM/DM patients with IP, suggesting that these cells proliferate by antigen stimulation.
Conserved amino acid sequence motifs in the CDR3 region of TCR BV genes from BALF-specific T cells of IP associated with PM/DM.
To examine the amino acid sequences of the CDR3 region in the TCR BV gene, we focused on the lungspecific T cell clones by SSCP analysis. DNAs encoding the TCR BV genes from BALF-specific bands were eluted from gels, followed by sequencing the corresponding CDR3 regions. As shown in Table III , the CDR3 region of the lungspecific accumulated T cell clones contained conserved amino acid motifs. In DM-1 patient, RGS, GLA, LQG, SGG, DRG, and GTS motifs were found in BV2-1, BV19-2 and BV20-3, BV5-1 and BV10-1, BV9-2 and BV13-3, BV10-2 and BV24-2, BV13-2 and BV20-3, and BV9-3 and BV24-2 clones, respectively. In PM-1 patient, TSGR, GGS, GQA, GAG motifs were found in BV4-2 and BV12-1, BV8-2 and BV20-1, BV9-2 and BV20-3, and BV12-3 and BV17-1 clones, respectively. In PM-2 patient, GTG motif was found in BV8-2 and BV16-2 clones, respectively (Table III) . In contrast, BALFspecific bands of the healthy subjects did not reveal any conserved amino acid motifs in the CDR3 region (Table IV) . The conserved amino acid motifs in the CDR3 region of TCR are summarized in Table V . These findings suggest that accumulated T cells in the lungs of patients with IP associated with PM/DM recognize a limited epitope on antigens.
Discussion
Recent studies on TCR of PBL and T cells infiltrating into muscles showed clonal expansion of CD8 + T cells in peripheral blood and muscles, although the TCR repertoire was heterogeneous (15) (16) (17) (18) (19) (20) (21) . In contrast, there are no studies on TCR of BALF T cells of PM/DM patients with IP. In the present study, we analyzed the TCR repertoire and sequences of TCR CDR3 regions and determined that the TCR BV repertoire was not skewed, but there were conserved amino acids in the CDR3 region in BALF T cells of PM and DM patients. We speculate that some T cells recognize the antigen in the context of HLA molecule and trigger autoimmune reaction. These results are similar to those reported in patients with IPF (13) but not those with sarcoidosis and atopic asthma (9) (10) (11) .
The conserved amino acid sequences in the CDR3 region of BALF T cells of patient DM1 are RGS motif in TCR BV2-1, BV19-2 and BV20-3, GLA motif in TCR BV5-1 and BV10-1, LQG motif in TCR 9-2 and BV13-3, SGG motif in TCR BV10-2 and BV24-2, DRG motif in TCR BV13-2 and Figure 1 . BALF-specific T cell clones. SSCP on TCR BV1-25 genes were carried out using cDNA from BALF and PBL of PM/DM patients and healthy subjects. Arrowheads show BALF-specific T cell clones. 
Table II. Accumulated T cell clones in BALF of patients with PM/DM + IP. -----------------------------------------------------------------------------------------------------
Numbers represent T cell clones accumulated in BAL of patients with PM/DM + IP. The distinct bands encoding TCR BV genes on SSCP were described as the number of BAL-specific T cell clones. -, not done. Table III . Conserved amino acid motifs in the CDR3 region of BALF-specific T cells of patients with PM/DM. Table IV . CDR3 region of BALF T cells of healthy subjects (HS).
, and GTS motif in TCR 9-3 and BV24-2 clones. In contrast, TSGR, GGS, GQA, GQA, GAG, and GTG motifs were found in TCR BV4-2 and BV12-1, BV8-2 and BV20-1, BV9-2 and BV20-3, BV12-3 and BV17-1, and BV8-2 and BV16-2 clones, respectively in patients with PM. These observations are specific for BALF T cells in PM and DM, since the same conserved amino acids motifs were not found in BALF T cells of IPF patients (13) . Moreover, the different conserved amino acids in the CDR3 region between DM and PM patients suggest that antigens recognized by BALF T cells might be different from each other. While some T cells clonally accumulate through antigen stimulation, many other T cells polyclonally expand by interleukin (IL)-2 stimulation. What are the antigens recognized by clonally expanded T cells? To our knowledge, there are no reports on antigens for BALF T cells in myositis, whereas heat-shock proteins or viral antigens are possible candidates for T cells in muscles of PM patients (15) . The antigens might be different from those in patients with sarcoidosis, because the TCR BV gene repertoire is not skewed but heterogeneous (8) (9) (10) . Moreover, antigens should not be the same as those in IPF patients (13) , because of the distinct conserved amino acid motifs in the TCR CDR3 region. BALF-specific T cell clones suggest that the antigens might be pulmonary antigens, e.g., autoantigens in alveolar epithelial cells or extracellular proteins such as viral or bacterial particles. Further studies on the antigens recognized by BALF T cells in PM/DM patients are necessary to clarity the role of T cells in the pathogenesis of myositis.
The autoaggressive CD8 + T cells seem to attack myocytes as cytotoxic T cells in a perforin-dependent manner. The majority of BALF T cells are CD8-positive similar to those infiltrating muscles, suggesting that BALF T cells may function as cytotoxic T cells against pulmonary epithelial cells and result in lung fibrosis. It is considered that PM and DM are pathogenetically different. In DM, there is no report that clonal expansion of T cells in the muscle is noted. Our results did not identify it clearly, but showed similar clonal expansion of T cells in BALF between PM and DM. This is considerable, therefore we need additional experimental data. However, the appropriate treatment for pulmonary fibrosis in patients with PM/DM is still non-specific therapy such as corticosteroid and immunosuppressant. Therefore, detection of clonally expanded T cells in BALF should be the first step in the development of specific regulators of cytotoxic T cells that induce interstitial pneumonitis in PM/DM patients.
In conclusion, we demonstrated clonal accumulation of BALF T cells in PM/DM patients with IP, suggesting that T cells in the lung expand via antigen-driven stimulation. Although the autoantigens recognized by pulmonary T cells have not yet been identified, we believe our results will be potentially useful for the design of new treatment strategies against IP in PM/DM patients that are specifically designed to target T cells and antigens. Table V . Summary of conserved amino acid motifs in the TCR CDR3 region. 
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